Transforming Growth Factor-Beta in Cancer Therapy, Volume II
Humana Press Inc. (Verlag)
978-1-58829-715-0 (ISBN)
Transforming Growth Factor-? In Developing and Advanced Cancers.- Transforming Growth Factor-? Signaling in Pancreas Development and Pancreatic Disease.- Role of Transforming Growth Factor-? in the Pathogenesis of Human Head and Neck Squamous Cell Carcinoma.- TGF-?, Smads and Cervical Cancer.- TGF-? Signaling and Biglycan in Pancreatic Cancer.- TGF-? Signaling in Endometrial Cancer.- TGF-? Ligands, TGF-? Receptors, and Lung Cancer.- Role of TGF-? in Osteolytic Bone Metastases.- Hormonal Regulation of Transforming Growth Factor-? in Breast Cancer.- TGF-? and Progression of Esophageal Cancer.- TGF-? and HER2/ErbB2 and Breast Cancer Progression.- TGF-? Dependent T-Cell Regulation in Colitis and Colon Cancer.- Role of Transforming Growth Factor-? in the Kidney — Physiology and Pathology.- Perturbations of TGF-? Signaling in Leukocytes as Drivers of Leukemogenesis and Epithelial Tumorigenesis.- Transforming Growth Factor-? in Brain Functions and Dysfunctions.- Inhibition of TGF-? Signaling in Multiple Myeloma and Its Bone Marrow Microenvironment.- Key Roles of TGF-? and Smad3 in Prostate Cancer.- Smad Signaling in Leukemic Growth and Differentiation: Crosstalk Between Smad and Multiple Pathways Through Activation of the TGF-? Type I Receptor.- Transforming Growth Factor-? in Cancer Treatment and Therapy.- High-Throughput Screening of Protein Interaction Networks in the TGF? Interactome: Understanding the Signaling Mechanisms Driving Tumor Progression.- Tumor Suppressor and Pro-progression Roles for TGF-? in Breast Cancer.- Tumor Suppressors p53 and TGF? Converge to Regulate the Alpha-Fetoprotein Oncodevelopmental Tumor Marker.- TGF?: Roles in DNA Damage Responses.- The Rationale for and Effects of Targeting TGF-? for Glioma Therapy.- TumorSuppressor Functions of TGF?1 in T Cells.- Therapeutic Effects of Adenovirus-Mediated Gene Transfer of TGF-? Signal Antagonists on Undesirable Epithelial-Mesenchymal Transition and Neovascularization.- Role of TGF-? in Tumor Protection and Antitumor Immunity.- Regulation of Angiogenesis and Tumor Growth by Thrombospondin-1.- Cancer-Associated Fibroblasts and the Role of TGF-?.- Adoptive Transfer of Tumor Reactive TGF-? Insensitive CD8+ T-cells for Cancer Therapy.- DNA Methylation and Histone Deacetylation Inhibitors as Potential Therapeutic Agents for the Reconstitution of TGF-? Signaling in Breast Cancer.- Reactive Stroma and Evolution of Tumors: Integration of Transforming Growth Factor-?, Connective Tissue Growth Factor, and Fibroblast Growth Factor-2 Activities.- TGF-? Signaling and Vascular Morphogenesis.- Aberrant Transforming Growth Factor-? Signaling in Human Pancreatic Cancer: Translational Implications.- TGF-? and Stromal Influences Over Local Tumor Invasion.- TGF-? at the Crossroads Between Inflammation, Suppression and Cancer.- Development of Inhibitors of Transforming Growth Factor-? Signaling for Therapy.- Transforming Growth Factor-? (TGF-?) Signaling Inhibitors in Cancer Therapy.- Targeting TGF-? as a Strategy to Ameliorate Intestinal Side Effects of Radiation Therapy.- Targeting Transforming Growth Factor-? in Metastasis: In Vitro and In Vivo Mechanisms.- Targeted Downregulation of TGF-?2 with AP 12009 in Tumor Therapy.- Modulating TGF-? Receptor Signaling: A Novel Approach of Cancer Therapy.- Engineering TGF-? Traps: Artificially Dimerized Receptor Ectodomains as High-affinity Blockers of TGF-? Action.- The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors inOncology.- Soluble Type II Transforming Growth Factor-? Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity.- Reversal of EMT by Small-Molecule Inhibitors of TGF-? Type I and II Receptors: Implications for Carcinoma Treatment.- Soluble TGF-? Type III Receptor Suppresses Malignant Progression of Human Cancer Cells.- Targeting Smad-Dependent TGF-? Signaling with Peptide Aptamers.- Rationale for Anti-TGF-? Antibody Therapy in Oncology.
Reihe/Serie | Cancer Drug Discovery and Development |
---|---|
Vorwort | C.-H. Heldin |
Zusatzinfo | 4 Illustrations, color; 160 Illustrations, black and white; XXVI, 786 p. 164 illus., 4 illus. in color. |
Verlagsort | Totowa, NJ |
Sprache | englisch |
Maße | 178 x 254 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
Naturwissenschaften ► Biologie ► Zellbiologie | |
ISBN-10 | 1-58829-715-2 / 1588297152 |
ISBN-13 | 978-1-58829-715-0 / 9781588297150 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich